Alliance Global lowered the firm’s price target on Tilray (TLRY) to $7 from $9 and keeps a Neutral rating on the shares. The company reported fiscal Q3 sales sales below estimates but beat on EBITDA as its savings initiative flowed through to earnings, the analyst tells investors in a research note. The firm cites uncertainty over hemp restrictions for the target cut.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Morning News Wrap-Up 4/1/26: Today’s Biggest Stock Market Stories!
- TLRY Earnings: Tilray Stock Soars After Smashing Wall Street’s Estimates
- Options Volatility and Implied Earnings Moves Today, April 01, 2026
- Ahead of Q3 Earnings, What Do Analysts Think About TLRY Stock?
- Tilray price target lowered to $7 from $10 at TD Cowen